C3 glomerulopathy has recently been described as a distinct entity. The underlying
mechanism is unregulated activation of the alternate pathway of the complement system …

C3 glomerulopathy is a recently defined entity that encompasses a group of kidney diseases
caused by abnormal control of complement activation with deposition of complement …

ABSTRACT C3 glomerulopathy is a rare renal disease that has been distinguished as a
renal disease for about 10 years. It is caused by an excessive activation of the alternative …

C3 glomerulopathy is a recently introduced pathological entity whose original definition was
glomerular pathology characterized by C3 accumulation with absent or scanty …

Background: C3 glomerulopathies (C3GN) are a group of rare kidney diseases associated
with impaired complement regulation. The effects of this disease include the accumulation of …

Objective To describe the clinicopathological features, complement abnormalities, triggers,
treatment, and outcomes of C3 glomerulopathy. Patients and Methods A total of 114 patients …

Abstract Background C3 glomerulopathy (C3GP) is characterized by deposition of
complement C3 with absence/traces of immunoglobulins in the glomeruli and categorized …

Objective: To investigate the clinicopathologic features and the prognosis in patients with C3
glomerulopathy (C3G). Methodology: Fifty four cases with C3G were enrolled into this …

In April 2012, a group of nephrologists organized a consensus conference in Cambridge
(UK) on type II membranoproliferative glomerulonephritis and decided to use a new …

ABSTRACT Background: C3 glomerulopathy (C3G) is an uncommon disease characterized
by the deposition of complement factors in the glomeruli due to overactivation and …